DANIELLE GOLDBERG: Open Payments
NPI 1417399783 · ANNAPOLIS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,059 in 105 payments from 19 companies in 2025. Trend: 2023 $1,991 · 2024 $1,540 · 2025 $2,059
Food & beverage: $1,987Education: $72
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $323 |
| Janssen Biotech, Inc. | 13 | $300 |
| Lilly USA, LLC | 8 | $170 |
| LEO Pharma Inc. | 5 | $157 |
| Novartis Pharmaceuticals Corporation | 7 | $151 |
| PFIZER INC. | 16 | $144 |
| Regeneron Healthcare Solutions, Inc. | 5 | $119 |
| Galderma Laboratories, L.P. | 5 | $98 |
| GENZYME CORPORATION | 3 | $96 |
| UCB, Inc. | 3 | $87 |
Products named: TREMFYA, SKYRIZI, DUPIXENT, TALTZ, CIBINQO, COSENTYX, ANZUPGO, RINVOQ.
Industry payments across MD — which companies pay providers there.
